ISB News

Dr. Nathan Price Named NAM Emerging Leader in Health and Medicine Scholar

Nathan Price

The National Academy of Medicine (NAM) today announced ISB’s Dr. Nathan Price as a 2019 Emerging Leader in Health and Medicine Scholar.

NAM’s Emerging Leaders in Health and Medicine Program provides a platform for a new generation of leaders to collaborate with the NAM and its members across generations and fields of expertise to advance science, combat persistent challenges in health and medicine, and spark transformative change to improve health for all.

“This is an incredible honor and opportunity,” Price said. “I look forward to the opportunities for mentorship, collaboration and innovation with fellow Emerging Leader in Health and Medicine scholars, NAM members, and experts spanning various scientific disciplines. I am humbled and thankful to Lee Hood and Gil Omenn for the nomination.”

Individuals named as scholars are early- to mid-career professionals from a wide range of health related fields, from microbiology and surgery to sociology and biomedical engineering. These young leaders are selected by NAM leadership to engage in a variety of activities throughout the National Academies of Sciences, Engineering, and Medicine (National Academies) over a three-year term.

“This is a significant award,” said Dr. Lee Hood, co-founder of ISB and one of only 20 people elected to all three National Academies. “It selects Nathan as one of the 10 outstanding leaders in the U.S. in modern medicine.”

This year’s class begins its term on July 1, 2019. Activities include biannual meetings in Washington, D.C., with NAM leadership; planning an annual Emerging Leaders Forum; participating in National Academies convening activities; publishing NAM Perspectives; and attending the NAM’s annual meeting each October.

In addition to Price, nine other individuals were named 2019 Emerging Leaders in Health and Medicine Scholars. They are:

  • Maria Elena Bottazzi, Ph.D., associate dean, National School of Tropical Medicine, and professor of pediatric tropical medicine and molecular virology and microbiology, Baylor College of Medicine
  • Oluwadamilola “Lola” Fayanju, M.D., M.A., M.P.H.S., assistant professor of surgery, Duke University
  • Ning (Jenny) Jiang, Ph.D., associate professor of biomedical engineering and oncology, University of Texas at Austin
  • Leora Horwitz, M.D., associate professor of population health and medicine, New York University School of Medicine
  • Mark Huffman, M.D., M.P.H., Quentin D. Young Professor of Health Policy and associate professor of preventive medicine and medicine, Northwestern University Feinberg School of Medicine; associate professor of food policy, The George Institute for Global Health; and associate professor of cardiovascular medicine, University of New South Wales
  • Raina Merchant M.D., M.S.H.P., associate vice president, Penn Medicine/Digital Health; and associate professor, department of emergency medicine, University of Pennsylvania
  • Brea Perry, Ph.D., professor of sociology, Indiana University
  • Hassan A. Tetteh, M.D., M.B.A., M.P.A., M.S., chief medical informatics officer, U.S. Navy; and associate professor of surgery, Uniformed Services University of the Health Sciences
  • Jeffrey K. Wickliffe Ph.D., M.S., associate professor, department of global environmental health sciences, Tulane University School of Public Health and Tropical Medicine

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.